June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Bone marrow-derived stem cells repair retinal vasculature in mouse model of oxygen-induced retinopathy
Author Affiliations & Notes
  • Baraa Noueihed
    Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
    Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Martine Blais
    Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Jose Carlos Rivera
    Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Ankush Madaan
    Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
    Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Sylvain Chemtob
    Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
    Ste-Justine Hospital Research Center, Montreal, QC, Canada
  • Footnotes
    Commercial Relationships Baraa Noueihed, None; Martine Blais, None; Jose Carlos Rivera, None; Ankush Madaan, None; Sylvain Chemtob, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2217. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Baraa Noueihed, Martine Blais, Jose Carlos Rivera, Ankush Madaan, Sylvain Chemtob; Bone marrow-derived stem cells repair retinal vasculature in mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2217.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Retinopathy of prematurity (ROP) is the leading cause of blindness in young children. The genesis of ROP progresses through two phases: 1) upon exposure to high O2 compared to that in utero, a process of retinal vaso-attenuation and vaso-obliteration takes place during arrest of microvascular development. 2) As a result of ensuing tissue ischemia an exaggerated neovascularization penetrates abnormally the vitreous predisposing to tragic retinal detachment. Accordingly, preservation of the microvasculature during the vaso-obliterative phase would be ideal. Because stem cells have been found to enhance coronary and renal revascularization following an ischemic insult, we surmised that stem cells can accelerate normal revascularization of the retina and in turn prevent aberrant intra-vitreal neovascularization.

Methods: Oxygen induced retinopathy (OIR) model of ROP replicates both phases of ROP genesis and was used herein. Two different cell types were isolated from mouse bone marrow: lineage negative (Lin-) hematopoietic stem cells and mesenchymal stem cells (MSC). Lin- cells were isolated by depleting the bone marrow mononuclear cells of mature cell types. MSCs were isolated in culture according to their natural adherence quality. These cells were then injected into the vitreous of OIR mice at postnatal day (P) 12 and retinas were analyzed at P17. Similarly, retinas were injected with MSC conditioned media.

Results: Mouse retinas collected at P17 from both MSC and Lin- injected intravitreally localized to the inner retina. Furthermore, mouse retinas injected with MSC or MSC conditioned media showed significant reduction in neovascularization and vaso-obliteration areas in comparison to Lin- injected retinas in OIR. To elucidate potential mechanisms to explain protective effects of MSC, we determined the expression of potentially relevant genes. Analysis revealed a 2-fold increase in the anti-inflammatory cytokine IL-10 and a 2-fold decrease in the pro-inflammatory cytokine IL-1β, along with an increase in pro-angiogenic growth factors VEGFA and FGF.

Conclusions: Findings reveal that bone marrow derived MSC migrate to the retina of OIR mice model and promote proper vascular repair (notably normal revascularization) via paracrine mechanisms involving decrease in pro-inflammatory cytokines and increase in cyto-protective growth factors. MSCs may exert therapeutic benefits in ROP.

Keywords: 721 stem cells • 706 retinopathy of prematurity • 700 retinal neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×